Floatz logo

Immunoglobulin G1, anti-(human/Macaca fascicularis/Macaca mulatta killer cell lectin-like receptor KLRD1) (human monoclonal DR-01 ?1-chain), disulfide with human monoclonal DR-01 ?-chain, dimer

LGLL - Large Granular Lymphocytic Leukemia

Dren Biomonoclonal_antibodyPhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the LGLL - Large Granular Lymphocytic Leukemia cohort.

Asset / SponsorPhaseRating
Fludarabine
Ohio State University Comprehensive Cancer Center
Phase 2BBB
CYCLOSPORIN A
Case Comprehensive Cancer Center
Phase 2BB
Cyclophosphamide
Case Comprehensive Cancer Center
Phase 2BB
Busulphan
Ohio State University Comprehensive Cancer Center
Phase 2BB
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Northwestern University
Phase 2B

View all 49 →

Same molecule, other indications

Immunoglobulin G1, anti-(human/Macaca fascicularis/Macaca mulatta killer cell lectin-like receptor KLRD1) (human monoclonal DR-01 ?1-chain), disulfide with human monoclonal DR-01 ?-chain, dimer is also rated in:

primary cutaneous aggressive epidermotropic CD8+ T-cell lymphomaDormant
CCC
Indicative ·
48 / 100
View asset →
primary cutaneous gamma-delta t-cell lymphomaDormant
CCC
Indicative ·
48 / 100
View asset →
subcutaneous panniculitis-like T-cell lymphomaDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →